<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00689754</url>
  </required_header>
  <id_info>
    <org_study_id>102007-022</org_study_id>
    <nct_id>NCT00689754</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed</brief_title>
  <acronym>NG</acronym>
  <official_title>The Role of Routine Placement of Nasogastric Tube in Patients With Suspected Upper Gastrointestinal Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Upper gastrointestinal tract hemorrhage (UGIH) remains a major cause of morbidity and
      mortality . Nasogastric aspiration (NGA) is routinely performed in patients with UGIH to
      obtain important clinical data and make therapeutic decisions. But routine use of NGA remains
      controversial with studies reporting its usefulness and its redundant clinical information.
      Early esophagogastroduodenoscopy (EGD) is recommended by most gastrointestinal societies to
      allow for risk stratification and to perform endoscopic treatments. The results of the NGA
      may assist to differentiate between high-risk versus low-risk lesions. Our hypothesis is that
      presence of NGA can identify lesions that require endoscopic treatment and provides important
      clinical information to guide the treating physician. In addition, we hypothesized that the
      results of the NGA influence the clinical decision of the treating physician regarding the
      prediction of the need for endoscopic therapy. This observational randomized cross-sectional
      study will enroll consecutive patients with presumed UGIH and randomized them to NGA and no
      NGA recording its results. All patients will receive an EGD and its results will also be
      recorded. Subsequently, we will evaluate if the NGA is important in identifying
      endoscopically significant lesions. The information gained will help guide clinicians
      evaluating patient with UGIH.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of patients predicted accurately to have a treatable lesion</measure>
    <time_frame>24h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications of nasogastric aspiration and lavage</measure>
    <time_frame>24h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between time to endoscopy and upper gastrointestinal hemorrhage</measure>
    <time_frame>24h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship of nasogastric aspirate and lavage with number of units of packed reb blood cells transfused</measure>
    <time_frame>24h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication of nasogastric tube placement and aspiration in cirrhotics</measure>
    <time_frame>24h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">282</enrollment>
  <condition>Gastrointestinal Hemorrhage</condition>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>NGA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive the standard of care to proceed with nasogastric tube placement, aspiration and lavage up to 1L of normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NO NGA</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient presenting with Upper GI hemorrhage going straight to endoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nasogastric tube placement</intervention_name>
    <description>standard nasogastric tube placement, aspiration and lavage up to 1L of normal saline</description>
    <arm_group_label>NGA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older then 21 years-old presenting with actual or reported: Hematemesis,
             Melena, or Hematemesis and Melena

        Exclusion Criteria:

          -  Refusal to participate

          -  Severe comorbid conditions making EGD hazardous for the patient, such as myocardial
             infarction &lt; 3 months with the exception if the myocardial infarction was caused by
             the UGIH, hemorrhagic or ischemic stroke &lt; 3 months, decompensated congestive heart
             failure, severe respiratory failure unless the patient is already intubated

          -  Survival expected to be less than 72h as judged by treating clinician

          -  Prisoners

          -  Patient with severe mental illness precluding the ability to obtain informed consent

          -  Ongoing anticoagulation which can not be reversed secondary to patient safety

          -  Strongly suspected gastrointestinal perforation

          -  Recent endoscopy (less than 30 days)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvio W Melo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center at Dallas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Parkland Memorial Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.utsouthwestern.edu</url>
    <description>UT Southwestern website</description>
  </link>
  <results_reference>
    <citation>Luk GD, Bynum TE, Hendrix TR. Gastric aspiration in localization of gastrointestinal hemorrhage. JAMA. 1979 Feb 9;241(6):576-8.</citation>
    <PMID>310892</PMID>
  </results_reference>
  <results_reference>
    <citation>Peterson WL. Evaluation and initial management of patients with upper gastrointestinal bleeding. J Clin Gastroenterol. 1981;3(Suppl 2):79-84.</citation>
    <PMID>6976367</PMID>
  </results_reference>
  <results_reference>
    <citation>Gilbert DA, Silverstein FE, Tedesco FJ, Buenger NK, Persing J. The national ASGE survey on upper gastrointestinal bleeding. III. Endoscopy in upper gastrointestinal bleeding. Gastrointest Endosc. 1981 May;27(2):94-102.</citation>
    <PMID>6971777</PMID>
  </results_reference>
  <results_reference>
    <citation>Cuellar RE, Gavaler JS, Alexander JA, Brouillette DE, Chien MC, Yoo YK, Rabinovitz M, Stone BG, Van Thiel DH. Gastrointestinal tract hemorrhage. The value of a nasogastric aspirate. Arch Intern Med. 1990 Jul;150(7):1381-4.</citation>
    <PMID>2196022</PMID>
  </results_reference>
  <results_reference>
    <citation>Basuk PM, Isenberg JI. Gastric lavage in patients with gastrointestinal hemorrhage. Yea or nay? Arch Intern Med. 1990 Jul;150(7):1379-80.</citation>
    <PMID>2369238</PMID>
  </results_reference>
  <results_reference>
    <citation>Cappell MS, Scarpa PJ, Nadler S, Miller SH. Complications of nasoenteral tubes. Intragastric tube knotting and intragastric tube breakage. J Clin Gastroenterol. 1992 Mar;14(2):144-7.</citation>
    <PMID>1556428</PMID>
  </results_reference>
  <results_reference>
    <citation>Levy H. Nasogastric and nasoenteric feeding tubes. Gastrointest Endosc Clin N Am. 1998 Jul;8(3):529-49. Review.</citation>
    <PMID>9654567</PMID>
  </results_reference>
  <results_reference>
    <citation>Barkun A, Bardou M, Marshall JK; Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2003 Nov 18;139(10):843-57.</citation>
    <PMID>14623622</PMID>
  </results_reference>
  <results_reference>
    <citation>Aljebreen AM, Fallone CA, Barkun AN. Nasogastric aspirate predicts high-risk endoscopic lesions in patients with acute upper-GI bleeding. Gastrointest Endosc. 2004 Feb;59(2):172-8.</citation>
    <PMID>14745388</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee SD, Kearney DJ. A randomized controlled trial of gastric lavage prior to endoscopy for acute upper gastrointestinal bleeding. J Clin Gastroenterol. 2004 Nov-Dec;38(10):861-5.</citation>
    <PMID>15492601</PMID>
  </results_reference>
  <results_reference>
    <citation>Cappell MS. Safety and efficacy of nasogastric intubation for gastrointestinal bleeding after myocardial infarction: an analysis of 125 patients at two tertiary cardiac referral hospitals. Dig Dis Sci. 2005 Nov;50(11):2063-70.</citation>
    <PMID>16240216</PMID>
  </results_reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2008</study_first_submitted>
  <study_first_submitted_qc>June 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2008</study_first_posted>
  <last_update_submitted>November 16, 2011</last_update_submitted>
  <last_update_submitted_qc>November 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Silvio Melo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>gastrointestinal hemorrhage</keyword>
  <keyword>gastrointestinal intubation</keyword>
  <keyword>endoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

